4//SEC Filing
Schobel Alexander Mark 4
Accession 0001214659-24-004307
CIK 0001398733other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 10:36 AM ET
Size
7.3 KB
Accession
0001214659-24-004307
Insider Transaction Report
Form 4
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
- Award
Common Stock
2024-03-07+82,500→ 1,065,371 total - Award
Non-Qualified Stock Option (right to buy)
2024-03-07+41,250→ 41,250 totalExercise: $5.68Exp: 2034-03-07→ Common Stock (41,250 underlying)
Footnotes (2)
- [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
- [F2]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001406836
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 10:36 AM ET
- Size
- 7.3 KB